Jason R. Krawic
University of Oklahoma Health Sciences Center(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Single‐cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing(2022)24 cited
- → Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival(2021)23 cited
- → Multiple Isomers of Photolumazine V Bind MR1 and Differentially Activate MAIT Cells(2024)15 cited
- → Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation(2024)13 cited
- → ScRNA-seq reveals tumor microenvironment remodeling induced by local intervention-based immunotherapy(2020)7 cited
- → Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors(2022)6 cited
- → Mutations outside the MR1 antigen binding groove differentially inhibit presentation of exogenous antigens(2025)5 cited
- → Immunopeptidome Analysis Demonstrates the Complexity of HLA-DQ: Implications for T Cell Allo-Recognition(2025)
- → Editorial: A new perspective in immune polymorphism (the HLA, KIR, and LILR genes)(2025)